Resona Asset Management Co. Ltd. acquired a new stake in Exponent, Inc. (NASDAQ:EXPO - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 432,179 shares of the business services provider's stock, valued at approximately $38,538,000. Resona Asset Management Co. Ltd. owned about 0.85% of Exponent at the end of the most recent quarter.
A number of other large investors have also recently bought and sold shares of EXPO. Vanguard Group Inc. increased its holdings in shares of Exponent by 1.3% during the 4th quarter. Vanguard Group Inc. now owns 5,345,503 shares of the business services provider's stock valued at $476,284,000 after acquiring an additional 67,296 shares during the last quarter. State Street Corp grew its holdings in Exponent by 0.7% during the third quarter. State Street Corp now owns 1,840,313 shares of the business services provider's stock valued at $212,151,000 after purchasing an additional 13,644 shares during the last quarter. Geode Capital Management LLC raised its position in shares of Exponent by 0.9% in the fourth quarter. Geode Capital Management LLC now owns 1,519,584 shares of the business services provider's stock valued at $135,419,000 after purchasing an additional 13,932 shares during the period. Wells Fargo & Company MN lifted its stake in shares of Exponent by 0.6% in the fourth quarter. Wells Fargo & Company MN now owns 739,710 shares of the business services provider's stock worth $65,908,000 after buying an additional 4,704 shares during the last quarter. Finally, JPMorgan Chase & Co. boosted its holdings in shares of Exponent by 63.6% during the 3rd quarter. JPMorgan Chase & Co. now owns 630,644 shares of the business services provider's stock worth $72,701,000 after buying an additional 245,086 shares during the period. 92.37% of the stock is currently owned by institutional investors.
Exponent Price Performance
NASDAQ:EXPO traded down $1.91 during midday trading on Thursday, reaching $77.88. The stock had a trading volume of 109,606 shares, compared to its average volume of 297,137. The stock has a market capitalization of $3.96 billion, a P/E ratio of 36.74 and a beta of 0.84. Exponent, Inc. has a 1-year low of $73.83 and a 1-year high of $115.75. The firm's fifty day simple moving average is $84.02 and its 200-day simple moving average is $93.72.
Exponent (NASDAQ:EXPO - Get Free Report) last posted its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.46 EPS for the quarter, topping analysts' consensus estimates of $0.40 by $0.06. Exponent had a return on equity of 27.27% and a net margin of 19.52%. During the same period last year, the firm earned $0.41 EPS. On average, equities research analysts anticipate that Exponent, Inc. will post 1.98 earnings per share for the current fiscal year.
Insider Transactions at Exponent
In other news, VP Richard Reiss sold 1,736 shares of the business's stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $85.93, for a total transaction of $149,174.48. Following the transaction, the vice president now owns 1,800 shares in the company, valued at approximately $154,674. The trade was a 49.10 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 2.10% of the company's stock.
About Exponent
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Featured Stories

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.